For western blotting, antibodies were used as follows: TRF2 (1:500, Cell Signaling Technology, 13136), p16 (1:1000, Proteintech, 10883-1-AP),
p21 Waf1/Cip1 (1:1000, Cell Signaling Technology, 2947),
γ-H2AX (ser139) (1:500, Cell Signaling Technology, 9718), 53BP1 (1:1000, Novus, NB100-304), p53 (1:1000, Cell Signaling Technologies, 2524), P-p53 (1:1000, Cell Signaling Technologies, 9284), Myc (1:1000, Cell signaling, Technology 2276),
P-TBK1 (Ser 172) (1:1000, Cell Signaling Technology, 5483), TBK1 (1:1000, Cell Signaling Technology, 3013),
NF-κB P-p65 (Ser 536) (1:1000, Cell Signaling Technology, 3033),
NF-κB p65 (1:1000, Cell Signaling Technology, 8242),
NF-κB1 p105/p50 (1:1000, Cell Signaling Technology, 3035), cGAS (1:1000, Cell Signaling Technology, 15102),
Actin (1:10 000, Sigma-Aldrich, A5-441),
anti-rabbit HRP (1:3000, Cell Signaling Technology, 7074),
anti-mouse HRP (1:3000, Cell Signaling Technology, 7076). For immunostaining:
γ-H2AX (JBW301) (1:500, Merck, 05-636),
H3K9me3 (1:400, Abcam, ab8898), 53BP1 (1:500, Novus, NB100-304), αSMA (Biotin) (1:500, Abcam, ab125057),
CD45 (Alexa Fluor 647) (1:50, Biolegend, 103123),
CD3 (Alexa Fluor 647) (1:50, Biolegend, 100209), CD68 (Alexa Fluor 647) (1:50, Biolegend, 137001),
ICAM-1 (1:50, Biolegend, 116102), VCAM-1 (1:50, Biolegend, 105702).
Uryga A.K., Grootaert M.O., Garrido A.M., Oc S., Foote K., Chappell J., Finigan A., Rossiello F., d’Adda di Fagagna F., Aravani D., Jorgensen H.F, & Bennett M.R. (2021). Telomere damage promotes vascular smooth muscle cell senescence and immune cell recruitment after vessel injury. Communications Biology, 4, 611.